(Q43160797)

15 November 2017

Changes in nutritional status and body composition during enzyme replacement therapy in adult-onset type II glycogenosis (English)

1 reference

enzyme replacement therapy

15 November 2017

0 references

author

Alfredo Costa

4

1 reference

15 November 2017

S Ravaglia

1

1 reference

15 November 2017

C Danesino

2

1 reference

15 November 2017

A Moglia

3

1 reference

15 November 2017

H Cena

5

1 reference

15 November 2017

L Maccarini

6

1 reference

15 November 2017

A Carlucci

7

1 reference

15 November 2017

A Pichiecchio

8

1 reference

15 November 2017

P Bini

9

1 reference

15 November 2017

P De Filippi

10

1 reference

15 November 2017

M Rossi

11

1 reference

15 November 2017

10 February 2010

1 reference

European Journal of Neurology

15 November 2017

1 reference

15 November 2017

17

1 reference

15 November 2017

957-962

1 reference

15 November 2017

7

1 reference

Recombinant human alpha-glucosidase from rabbit milk in Pompe patients.

15 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Protein turnover in acid maltase deficiency before and after treatment with a high protein diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Management and treatment of glycogenosis type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Dietary treatment in late-onset acid maltase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

The effect of L-alanine therapy in a patient with adult onset glycogen storage disease type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

L-alanine supplementation in late infantile glycogen storage disease type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Glycogen storage disease type II (Pompe disease)--influence of enzyme replacement therapy in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Early administration of enzyme replacement therapy for Pompe disease: short-term follow-up results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2010.02959.X

10.1111/J.1468-1331.2010.02959.X

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference